• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6个月后老年人对SARS-CoV-2感染的免疫反应降低。

Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months.

作者信息

Luo Qin, Song Qinqin, Li Yan, Zong Kexin, Liu Ti, He Junming, Mei Guoyong, Du Haijun, Xia Zhiqiang, Liu Mi, Song Juan, Gao Chen, Xia Dong, Xue Guangyu, Tian Wenyan, Qu Yinli, Kou Zengqiang, Dong Zhongjun, Han Jun

机构信息

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Intelligent Monitoring, Early Warning, and Prevention and Control of Infectious Diseases, Shandong Institute of Preventive Medicine, Jinan, China.

出版信息

Front Immunol. 2025 May 9;16:1596065. doi: 10.3389/fimmu.2025.1596065. eCollection 2025.

DOI:10.3389/fimmu.2025.1596065
PMID:40416973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12098630/
Abstract

OBJECTIVES

To evaluate the immune persistence and cross-immune response of elderly individuals after Omicron BA.5 infections.

METHOD

The neutralizing antibodies against WT, BA.5, XBB.1 and EG.5 strains were analyzed. The T/B-cell subsets' responses were tested through intracellular cytokine staining and flow cytometry.

RESULTS

The neutralizing antibodies titers against WT and BA.5 strain, remaining high level for at least 6 months, were higher than that of both XBB.1 and EG.5 variants. The neutralizing antibodies of WT, BA.5, XBB.1, and EG.5 strains in the elderly were slightly lower than those in middle-age. The memory B cells decreased rapidly in the elderly, and Tfh, Th17 cells of the elderly continued to increase for only 3 months, while Tfh and Th17 cells increased in the middle-aged for over 6 months. For the elderly, after peptide stimulation, unswitched/switched memory B cells decreased, while double negative B cells displayed higher proliferation. The proportions of both naïve and Temra cells in CD4 and CD8 T cells declined, whereas those of Tcm and Tem cells elevated. In the meantime, both CD69 and CD38 T cells decreased, but the frequencies of PD-1 and CTLA-4 of CD4 and CD8 T cells showed an increasing trend. The proportions of PD-1 and CTLA-4 cells also increased in older people with long COVID symptoms at 3m post-infection.

CONCLUSIONS

Omicron BA.5 infection induced lower neutralizing antibodies against XBB.1 and EG.5 variant. The decrease of memory B cells, CD69 and CD38T cells, as well as the increase of PD-1, CTLA-4 of CD4/CD8T cells and double negative B cells, indicate that sustained immune responses against BA.5 infection may wane more rapidly in elderly populations.

摘要

目的

评估老年人感染奥密克戎BA.5后免疫持久性和交叉免疫反应。

方法

分析针对野生型、BA.5、XBB.1和EG.5毒株的中和抗体。通过细胞内细胞因子染色和流式细胞术检测T/B细胞亚群反应。

结果

针对野生型和BA.5毒株的中和抗体滴度至少6个月保持高水平,高于XBB.1和EG.5变体。老年人中野生型、BA.5、XBB.1和EG.5毒株的中和抗体略低于中年人。老年人记忆B细胞迅速减少,老年人的滤泡辅助性T细胞(Tfh)、辅助性T细胞17(Th17)仅持续增加3个月,而中年人中Tfh和Th17细胞增加超过6个月。对于老年人,肽刺激后,未转换/转换记忆B细胞减少,而双阴性B细胞增殖更高。CD4和CD8 T细胞中初始和终末分化效应记忆T细胞(Temra)比例下降,而中央记忆T细胞(Tcm)和效应记忆T细胞(Tem)比例升高。同时,CD69和CD38 T细胞减少,但CD4和CD8 T细胞的程序性死亡受体1(PD-1)和细胞毒性T淋巴细胞相关蛋白4(CTLA-4)频率呈上升趋势。感染后3个月有长期新冠症状的老年人中PD-1和CTLA-4细胞比例也增加。

结论

奥密克戎BA.5感染诱导产生的针对XBB.1和EG.5变体的中和抗体较低。记忆B细胞、CD69和CD38 T细胞减少,以及CD4/CD8 T细胞的PD-1、CTLA-4和双阴性B细胞增加,表明老年人群体中针对BA.5感染的持续免疫反应可能衰退更快。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/86a9950a77a9/fimmu-16-1596065-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/01f0a9085359/fimmu-16-1596065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/e3c0e02a319b/fimmu-16-1596065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/2ffa912cc89b/fimmu-16-1596065-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/af49d19c0a94/fimmu-16-1596065-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/c176f220258c/fimmu-16-1596065-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/9ab317f8564a/fimmu-16-1596065-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/86a9950a77a9/fimmu-16-1596065-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/01f0a9085359/fimmu-16-1596065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/e3c0e02a319b/fimmu-16-1596065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/2ffa912cc89b/fimmu-16-1596065-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/af49d19c0a94/fimmu-16-1596065-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/c176f220258c/fimmu-16-1596065-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/9ab317f8564a/fimmu-16-1596065-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab68/12098630/86a9950a77a9/fimmu-16-1596065-g007.jpg

相似文献

1
Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months.6个月后老年人对SARS-CoV-2感染的免疫反应降低。
Front Immunol. 2025 May 9;16:1596065. doi: 10.3389/fimmu.2025.1596065. eCollection 2025.
2
Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count.在接受基于CD4 T细胞计数的抗逆转录病毒治疗的艾滋病毒感染者中,原始SARS-CoV-2疫苗加强剂量后针对野生型SARS-CoV-2病毒和奥密克戎BA.5变体的中和活性及T细胞反应
J Korean Med Sci. 2025 Mar 10;40(9):e28. doi: 10.3346/jkms.2025.40.e28.
3
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters.XBB.1.5 rS 疫苗在叙利亚仓鼠中针对 SARS-CoV-2 的 EG.5.1 变异株的免疫原性和疗效。
J Virol. 2024 Oct 22;98(10):e0052824. doi: 10.1128/jvi.00528-24. Epub 2024 Sep 4.
4
Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients.肾移植受者感染奥密克戎或接种奥密克戎BA.4/5疫苗后对SARS-CoV-2刺突蛋白免疫反应的比较。
Front Immunol. 2025 Jan 14;15:1476294. doi: 10.3389/fimmu.2024.1476294. eCollection 2024.
5
Ad5-nCoV boosted vaccine and reinfection-induced memory T/B cell responses and humoral immunity to SARS-CoV-2: based on two prospective cohorts.Ad5-nCoV 增强型疫苗和再感染诱导的记忆 T/B 细胞反应及体液免疫对 SARS-CoV-2 的作用:基于两项前瞻性队列研究。
Emerg Microbes Infect. 2024 Dec;13(1):2412619. doi: 10.1080/22221751.2024.2412619. Epub 2024 Oct 28.
6
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.mRNA 疫苗接种后肾移植受者对 SARS-CoV-2 奥密克戎亚变种的中和抗体反应和细胞反应。
Sci Rep. 2024 May 28;14(1):12176. doi: 10.1038/s41598-024-63147-z.
7
Comparative immunogenicity of monovalent and bivalent adenovirus vaccines carrying spikes of early and late SARS-CoV-2 variants.比较携带早期和晚期 SARS-CoV-2 变异株刺突的单价和双价腺病毒疫苗的免疫原性。
Emerg Microbes Infect. 2024 Dec;13(1):2387447. doi: 10.1080/22221751.2024.2387447. Epub 2024 Aug 19.
8
Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations.重复接种疫苗对奥密克戎亚变体中和抗体反应的有限免疫印记。
Int J Infect Dis. 2024 Oct;147:107198. doi: 10.1016/j.ijid.2024.107198. Epub 2024 Aug 6.
9
Distinct immune memory induced by SARS-CoV-2 in convalescent liver transplant recipients.新冠康复期肝移植受者体内由新冠病毒诱导产生的独特免疫记忆
Front Immunol. 2025 Apr 2;16:1420150. doi: 10.3389/fimmu.2025.1420150. eCollection 2025.
10
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants.基于原始受体结合域(RBD)抗原的抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清学与针对奥密克戎变异株的中和抗体的存在不相关。
Microbiol Spectr. 2025 Jan 7;13(1):e0156824. doi: 10.1128/spectrum.01568-24. Epub 2024 Nov 20.

本文引用的文献

1
Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.中国奥密克戎BA.5和XBB毒株流行后老年人群加强免疫接种的流行病学特征及抗体动力学
J Med Virol. 2024 May;96(5):e29640. doi: 10.1002/jmv.29640.
2
Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals.老年个体中预先存在的新冠病毒特异性T细胞反应发生改变。
Clin Immunol Commun. 2022 Dec;2:6-11. doi: 10.1016/j.clicom.2021.12.001. Epub 2021 Dec 23.
3
EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19.
EG.5(Eris)和 BA.2.86(Pirola):两种新的 SARS-CoV-2 亚变体:旧 COVID-19 的新面貌。
Infection. 2024 Apr;52(2):337-343. doi: 10.1007/s15010-023-02146-0. Epub 2024 Jan 3.
4
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.多次感染奥密克戎会颠覆原始 SARS-CoV-2 免疫印记。
Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22.
5
Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination.尽管基于原型的疫苗接种反复进行,但在 BA.5/ BF.7 突破性感染后,针对奥密克戎亚变种的中和作用随着病毒进化和老化而减弱。
Emerg Microbes Infect. 2023 Dec;12(2):2249121. doi: 10.1080/22221751.2023.2249121. Epub 2023 Sep 5.
6
SARS-CoV-2-specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022.2022 年末北京感染浪潮后康复者体内的 SARS-CoV-2 特异性抗体和 T 细胞免疫。
J Infect. 2023 Nov;87(5):413-419. doi: 10.1016/j.jinf.2023.08.010. Epub 2023 Aug 29.
7
A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population.合并症患者与正常人群中三种不同新冠病毒加强针的免疫原性、抗体持久性及安全性的比较研究
Vaccines (Basel). 2023 Aug 17;11(8):1376. doi: 10.3390/vaccines11081376.
8
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection.感染 BA.5 后,针对 XBB 奥密克戎亚变种的中和抗体水平较低。
Signal Transduct Target Ther. 2023 Jun 19;8(1):252. doi: 10.1038/s41392-023-01495-4.
9
Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1.突破性感染 SARS-CoV-2 BA.5 或 BF.7 后的血清对 XBB.1.5 和 CH.1.1 的中和活性较低。
Emerg Microbes Infect. 2023 Dec;12(2):2225638. doi: 10.1080/22221751.2023.2225638. Epub 2023 Jul 12.
10
CD4 T cell memory.CD4 T 细胞记忆。
Nat Immunol. 2023 Jun;24(6):903-914. doi: 10.1038/s41590-023-01510-4. Epub 2023 May 8.